verywellhealth on MSN15h
Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult
Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...
For people who couldn’t get Ozempic or Wegovy, 2025 could be your year (if you can afford it)
It’s quickly become evident that GLP-1 drugs for diabetes, weight loss, and more are the new wonder drugs—if only people ...
UK's private obesity drug market chooses Lilly's Mounjaro over Wegovy
STORY: The battle of the weight loss drugs continues, as Britons paying privately for obesity drugs are increasingly choosing ...
The New Republic on MSN10hOpinion
Trump Suddenly Changes His Tune With New Daylight Savings Time Promise
“The Republican Party will use its best efforts to eliminate Daylight Saving Time, which has a small but strong constituency, ...
Decatur Daily4h
Alabama task force grapples with high costs of weight-loss drugs amid rising obesity rates
A joint task force charged with researching and proposing solutions for Alabama’s high obesity and diabetes rates appeared ...
The Ozempic Flip-Flop
They rationed their remaining supplies, stretching the weekly injections to 10 days, two weeks, even three weeks. They ...